Enzyme studies on placenta, cultured skin fibroblasts, and erythrocytes from two sisters with the inborn error 5-oxoprolinuria (pyroglutamic aciduria) indicate that the metabolic lesion in this disease is at the glutathione syntbetase (EC 6.3.2.3) step of the 7y-glutamyl cycle. Excessive urinary excretion of 5-oxoproline by these patients appears to be associated with increased synthesis of -y-glutamyl-cysteine and formation of 5-oxoproline from this dipeptide. Thus, 5-oxoproline is produced in amounts that exceed the normal capacity of 5-oxoprolinase to convert it to glutamate. The data indicate that it may be possible to identify individuals who are heterozygous for this trait by determinations of erythrocyte glutathione synthetase.Previous studies on glutathione have indicated that its synthesis and utilization are integrated in a series of enzymecatalyzed reactions, which have been termed the y-glutamyl cycle. The y-glutamyl cycle consists of six enzyme-catalyzed reactions ( Fig. 1): amino acid-dependent breakdown of glutathione to yield y-glutamyl amino acid and cysteinyl-glycine catalyzed by -y-glutamyl transpeptidase (EC 2.3.2.2) conversion of -y-glutamyl amino acid to 5-oxoproline4 and the corresponding free amino acid catalyzed by 'y-glutamyl cyclotransferase (EC 2.3.2.4), enzymatic hydrolysis of cysteinylglycine to cysteine and glycine, conversion of 5-oxoproline to glutamate catalyzed by 5-oxoprolinase, and the two-step synthesis of glutathione from glutamate, cysteine, and glycine catalyzed by -y-glutamyl-cysteine synthetase (EC 6.3.2.2) and glutathione (GSH) synthetase (EC 6.3.2.3). The evidence for the existence of the cycle and for its involvement in amino-acid transport has been reviewed recently (1-3). §In 1970 Jellum et al. (5) reported on an interesting patient who had a massive urinary excretion of 5-oxoproline (about 30 g/day compared to less than a few mg/day in normal individuals).f This patient was a 19-year-old male with metabolic acidosis and multiple neurological symptoms such as mental retardation, spastic tetraparesis, and ataxia. The patient was at first thought to have a defect in the urea cycle (5), but subsequent studies (7-10) have indicated a lesion in the y-glutamyl cycle, although the exact location was not determined.A (12). Since 1 year of age she is known to have excreted in the urine more than 6 g of 5-oxoproline per day, and her plasma concentration of 5-oxoproline has been 2-5 mM (11,12). Studies in which this patient was given [14C]5-oxoproline are consistent with the conclusion that about 25% of the amount of 5-oxoproline formed by this patient is excreted and that the rernainder is metabolized (11); a similar conclusion may now be drawn from the studies done on the first patient (8).Studies on the peripheral leukocytes of the second patient have indicated the presence of 5-oxoprolinase (11). The young girl with 5-oxoprolinuria has recently acquired a sister who suffers from the same inborn error of metabclism (12). 13oth patients, in addition to increased co...